137 related articles for article (PubMed ID: 37024066)
1. Ligand-free high loading capacity ursolic acid self-carried nanovesicles enable hepatocyte targeting via absorbing apolipoproteins.
Yuan C; Fan W; Zhou T; Sun D; Liu H; He Z; Wang Y
Int J Pharm; 2023 May; 638():122931. PubMed ID: 37024066
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
Biswas S; Mukherjee PK; Harwansh RK; Bannerjee S; Bhattacharjee P
Drug Dev Ind Pharm; 2019 Jun; 45(6):946-958. PubMed ID: 30767678
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo.
Ma XY; Zhang M; Fang G; Cheng CJ; Wang MK; Han YM; Hou XT; Hao EW; Hou YY; Bai G
Acta Pharmacol Sin; 2021 Jul; 42(7):1101-1110. PubMed ID: 33028983
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo.
Zhang H; Zheng D; Ding J; Xu H; Li X; Sun W
Int J Nanomedicine; 2015; 10():1909-20. PubMed ID: 25792825
[TBL] [Abstract][Full Text] [Related]
5. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
6. Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling.
Yang Y; Zhao Z; Liu Y; Kang X; Zhang H; Meng M
J Gastroenterol Hepatol; 2015 Mar; 30(3):609-18. PubMed ID: 25168399
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
Das S; Ghosh S; De AK; Bera T
Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
9. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles.
Zhou XJ; Hu XM; Yi YM; Wan J
Drug Dev Ind Pharm; 2009 Mar; 35(3):305-10. PubMed ID: 18798089
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption.
Yan X; Liu X; Wang Y; Ren X; Ma J; Song R; Wang X; Dong Y; Fan Q; Wei J; Yu A; Sui H; She G
Eur J Nutr; 2022 Feb; 61(1):115-126. PubMed ID: 34215920
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy.
Di Francesco M; Celia C; Primavera R; D'Avanzo N; Locatelli M; Fresta M; Cilurzo F; Ventura CA; Paolino D; Di Marzio L
Int J Pharm; 2017 Aug; 528(1-2):18-32. PubMed ID: 28559215
[TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity.
Song J; Wang Y; Song Y; Chan H; Bi C; Yang X; Yan R; Wang Y; Zheng Y
AAPS PharmSciTech; 2014 Feb; 15(1):11-19. PubMed ID: 24022345
[TBL] [Abstract][Full Text] [Related]
13. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
[TBL] [Abstract][Full Text] [Related]
14. Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effects.
Ji X; Tang Q; Pang P; Wu J; Kirk TB; Xu J; Ma D; Xue W
Colloids Surf B Biointerfaces; 2018 Oct; 170():293-302. PubMed ID: 29936382
[TBL] [Abstract][Full Text] [Related]
15. Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.
Markowski A; Jaromin A; Migdał P; Olczak E; Zygmunt A; Zaremba-Czogalla M; Pawlik K; Gubernator J
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628352
[TBL] [Abstract][Full Text] [Related]
16. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
17. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
18. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
19. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).
Hussain H; Green IR; Ali I; Khan IA; Ali Z; Al-Sadi AM; Ahmed I
Expert Opin Ther Pat; 2017 Sep; 27(9):1061-1072. PubMed ID: 28637397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
